Finoriq research workspace
Tempus AI, Inc. (TEM) SEC Filings & Filing Highlights
Tempus AI, Inc. operates as a healthcare technology company in the United States. Review TEM SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
- Company
- Tempus AI, Inc. (TEM)
- Ticker
- TEM
- Market Cap
- $8.7B
- Latest Price
- $48.28
- Industry
- Software & Data Processing
Tempus AI, Inc. (TEM) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Tempus AI, Inc. (TEM).
| Event | Form | Date |
|---|---|---|
| Tempus AI, Inc. held its 2026 Annual Meeting of Stockholders on May 21, 2026. In accordance wit...Tempus AI, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on May 21, 2026. In accordance with the... | 8-K5.07 | 2026-05-22 |
| Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering toTempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to | 8-K8.01 | 2026-05-13 |
| Unregistered Sale of Equity SecuritiesThe Company offered and sold the Notes to the initial purchasers in reliance on the exemption from registration provided by Section 4(a)(2)... | 8-K3.02 | 2026-05-13 |
| Debt or FinancingDebt or Financing | 8-K2.03 | 2026-05-13 |
| Tempus AI, Inc.: Agreement terminationOn May 12, 2026, the Company used a portion of the net proceeds from the Offering to repay in full all obligations outstanding under that c... | 8-K1.02 | 2026-05-13 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.